Michael Sweeney

Michael Sweeney

Chief Tech/Sci/R&D Officer at RESVERLOGIX CORP.

Net worth: 10 406 $ as of 30/06/2026

65 year
Health Technology
Consumer Services

Profile

Dr. Michael T.
Sweeney
, MD, is a Senior Vice President-Clinical Development at Resverlogix Corp.
Dr. Sweeney was previously employed as a Chief Medical Officer, VP-Research & Development by Depomed, Inc., a Vice President-Medical Affairs by CV Therapeutics, Inc., a Senior Director-Urology Global Medial Group Leader by Pfizer Inc., and a Senior Clinical Pharmacologist by Zeneca Group Plc.
He received his doctorate degree from The University of Liverpool.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/04/2025 155,312 ( 0.05% ) 10 406 $ 30/06/2026

Michael Sweeney active positions

CompaniesPositionStart
RESVERLOGIX CORP. Chief Tech/Sci/R&D Officer 03/11/2014

Former positions of Michael Sweeney

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 01/01/2014
Chief Tech/Sci/R&D Officer 01/09/2007
PFIZER INC. Corporate Officer/Principal 01/01/2003
Corporate Officer/Principal -
See the detail of Michael Sweeney's experience

Training of Michael Sweeney

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

74

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Sweeney